Public Company News

OneConnect International CTO at Fortune Brainstorm AI: Future of Finance Demands Hybrid AI Approach for Trust and Control

SINGAPORE, July 28, 2025 /PRNewswire/ -- The future of artificial intelligence in finance lies in a hybrid approach that combines the generative power of large models with the precision of traditional AI to ensure trust and control, said Dr.Ming Jin, International CTO of OneConnect Financial Tech...

2025-07-28 18:41 3952

SuperX Announces Plan for the Establishment of its AI Supply Center in Japan to Accelerate End-to-End Solution Delivery

The new hub will serve as a regional center for the integration and delivery of SuperX's core AI Server and HVDC products, with a projected annual capacity of 10,000 high-performance AI servers to meet accelerating demand inJapan. SINGAPORE, July 28, 2025 /PRNewswire/ -- Super X AI Technology Lim...

2025-07-28 18:30 4751

Quhuo Partners with NIU World to Launch Innovative Fresh Beef Chain Brand Incubation Platform, Accelerating the Transformation of China's Fresh Beef Consumption Market

BEIJING, July 28, 2025 /PRNewswire/ -- Quhuo Limited (NASDAQ: QH) ("Quhuo" or the "Company"), a leading tech-enabled service platform, today announced a strategic partnership with NIU World, a local food group inChina, to jointly establish a new chain brand incubation platform focused on fresh be...

2025-07-28 18:00 2935

Caliway Announces FDA Clearance of IND Application for CBL-514 to Proceed with SUPREME-01, the First Global Pivotal Phase 3 Study for Reducing Abdominal Subcutaneous Fat

* CBL-514, Caliway's first-in-class lipolysis drug candidate, has been granted clearance from the U.S. FDA to proceed with SUPREME-01, a global, multicenter, pivotal Phase 3 study. Subject recruitment is expected to begin in the U.S. andCanada in Q3 2025. * CBL-514 is the first 505(b)(1) inve...

2025-07-28 17:51 4028

China Literature to Report First Half 2025 Financial Results on August 12, 2025

- Earnings Conference Call to be Held on Tuesday, August 12, 2025 at 8:00 pm (Hong Kong Time) / 8:00 am (U.S. Eastern Time) HONG KONG, July 28, 2025 /PRNewswire/ -- China Literature Limited ("China Literature" or "the Company", 0772.HK), a leading online literature and intellectual property ("IP...

2025-07-28 17:39 5151

FinVolution Group Publishes Seventh Annual ESG Report

SHANGHAI, July 28, 2025 /PRNewswire/ -- FinVolution Group ("FinVolution," or the "Company") (NYSE: FINV), a leading fintech platform, today announced it has released its 2024 Environmental, Social, and Governance (ESG) report, the Company's seventh consecutive annual ESG report. The report provid...

2025-07-28 17:30 2777

Cheetah Mobile to Acquire Controlling Stake in UFACTORY to Accelerate Its Robotics Commercialization Strategy

BEIJING, July 28, 2025 /PRNewswire/ -- Cheetah Mobile Inc. (NYSE: CMCM) ("Cheetah Mobile" or the "Company"), aChina-based IT company, today announced that one of its majority-owned subsidiaries has signed a definitive agreement to acquire an equity interest of 60.8% in Shenzhen UFACTORY Technolog...

2025-07-28 17:00 3476

Doosan Robotics Accelerates Push to Become an AI Robot Solutions Leader

— Acquires 89.59% stake in U.S. automation engineering firm ONExia — Strengthens future growth engine with AI•humanoid technology•top-tier talent and builds an R&D Innovation center EXTON, Pa. and SEONGNAM, South Korea, July 28, 2025 /PRNewswire/ -- Doosan Robotics is stepping up its transformati...

2025-07-28 16:10 2486

Alteogen Receives Positive CHMP Opinion for Aflibercept Biosimilar, 'EYLUXVI® (ALT-L9)'

* CHMP positive opinion is based on a robust analytical, non-clinical and clinical data package comparing EYLUXVI® to the reference product Eylea® * Upon approval, EYLUXVI® will be Alteogen's second biosimilar product, following a Herceptin® biosimilar by Alteogen's license partner Qilu Pharm...

2025-07-28 14:00 3380

NMPA Accepts sNDA for Ivonescimab in Combination with Chemotherapy as First-Line Treatment for Advanced Squamous Non-Small Cell Lung Cancer

HONG KONG, July 28, 2025 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") is pleased to announce that the National Medical Products Administration (NMPA) has accepted the supplementary New Drug Application (sNDA) for ivonescimab (PD-1/VEGF bispecific antibody) in combination with ...

2025-07-28 12:14 4001

Antengene Announces Poster Presentation of ATG-022 (Claudin 18.2 ADC) at ESMO 2025

SHANGHAI and HONG KONG, July 28, 2025 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative, commercial-stage global biopharmaceutical company dedicated to discovering, developing and commercialising first-in-class and/or best-in-class medicines for canc...

2025-07-28 10:40 2339

Galan Lithium Limited: Incentive Regime for HMW Project in Argentina

PERTH, Australia, July 28, 2025 /PRNewswire/ -- Galan Lithium Limited (ASX: GLN) ("Galan" or "the Company") is pleased to advise that the Comite Evaluador de Proyectos RIGI, responsible for awarding the Argentine Government's Régimen de Incentivo para Grandes Inversiones (the incentive regime for...

2025-07-28 09:00 2326

Ascletis Announces First Participants with Obesity or Overweight Dosed in Its U.S. 12-week Phase IIa Study Evaluating Once-Monthly Subcutaneous Depot Formulation of Small Molecule GLP-1R Agonist ASC30

-          First participants with obesity or overweight with at least one w eight-related comorbidity have been dosed in a U.S. 12-week Phase IIa study with once-monthly subcutaneous (SQ) depot formulation of small molecule GLP-1  receptor agonist ASC30. -          Ultra-long-acting SQ depot for...

2025-07-28 08:15 2547

Harbour BioMed Announces Positive Profit Alert for 2025 Interim Results

CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SHANGHAI, July 27, 2025 /PRNewswire/ -- Harbour BioMed (the "Company"; HKEX: 02142), a global biopharmaceutical company focused on the discovery and development of novel antibody therapeutics in immunology and oncology, today announced a positive prof...

2025-07-28 08:11 2774

Consecutive Victories by TGE and AMTD Against IP Infringements

PARIS and NEW YORK and SINGAPORE, July 25, 2025 /PRNewswire/ -- AMTD Group Inc. ("AMTD" or the "Group"), alongside The Generation Essentials Group ("TGE"), a subsidiary of the Group under AMTD Digital, jointly announce that as a global owner of fashion magazines published under "L'OFFICIEL AMTD" ...

2025-07-25 22:58 6597

Newborn Town Reports First-Half 2025 Operating Data: Revenue Projected to Exceed RMB 3 Billion, Marking Over 38% Year-on-Year Growth

HONG KONG, July 25, 2025 /PRNewswire/ -- Newborn Town, a leading global social entertainment company, released its unaudited operating data for the first half of 2025. For the six months ending30 June 2025, the company's total revenue is estimated to reachRMB 3,135 million to RMB 3,215 million, r...

2025-07-25 21:55 6933

NYSE Content Advisory: Pre-market update + Accelerant celebrates IPO

NEW YORK, July 25, 2025 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins.    NYSE Content Advisory: Pre-market update + Accelerant celebrates...

2025-07-25 20:55 3980

TROOPS, Inc. (NASDAQ: TROO) Intends to Bolster Shareholder Value with Strategic Stock Repurchase

HONG KONG, July 25, 2025 /PRNewswire/ -- TROOPS, Inc. (NASDAQ: TROO) ("TROOPS" or the "Company") today announced that the Company has initiated its stock repurchasing plan by entering into a stock repurchase agreement (the "Stock Repurchase Agreement") with an existing shareholder (the "Sharehold...

2025-07-25 20:30 4476

Nature's Miracle Holding Inc. ("NMHI") Management and a Lender Invested $1.69 Million in NMHI Shares through Liability and Debt Conversion

ONTARIO, Calif., July 25, 2025 /PRNewswire/ -- Nature's Miracle Holding Inc. (OTCQB:NMHI) ("Nature's Miracle" or the "Company"), a leader in vertical farming technology today announced that certain members of the Company's management team including CEO, President and CFO and a Lender agreed to co...

2025-07-25 20:30 4272

Amcor announces registered exchange offers

ZURICH, July 25, 2025 /PRNewswire/ -- Amcor plc ("Amcor") (NYSE: AMCR, ASX: AMC) today announced the commencement of offers (the "exchange offers") by Amcor Flexibles North America, Inc., Amcor's wholly-owned subsidiary (the "Issuer") and the guarantors, including Amcor (the "Guarantors"), to exc...

2025-07-25 20:12 3665